HSD17B10 (also known as HADH2, SCHAD, SDR5C1, MRPP2, and historically ERAB/ABAD) is a mitochondrial-matrix protein of the short-chain dehydrogenase/reductase (SDR) family that acts as a functional homotetramer and is a genuinely moonlighting, multifunctional enzyme. In its catalytic role it is an NAD+-dependent dehydrogenase whose physiologically important activity is (S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) in L-isoleucine catabolism, oxidizing (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to 2-methyl-3-oxobutanoyl-CoA. It has broad (S)-3-hydroxyacyl-CoA dehydrogenase activity on short/medium straight-chain acyl-CoAs and weaker intrinsic 17-beta-/3-alpha-hydroxysteroid and alcohol dehydrogenase activities toward steroid hormones (including the neurosteroid allopregnanolone/brexanolone), bile acids and other substrates. Independently of its enzymatic activity, it moonlights as MRPP2, an essential non-catalytic subunit of mitochondrial RNase P (together with the methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3), which performs 5'-end processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex additionally catalyzes N1-methylation of purine-9 (m1A9/m1G9) of mt-tRNAs and acts as a tRNA-maturation platform that supports downstream 3'-processing by ELAC2 and 3'-CCA addition by TRNT1. It localizes to the mitochondrial matrix and associates with the mitochondrial nucleoid. Loss-of-function mutations in the X-linked HSD17B10 gene cause HSD10 mitochondrial disease (a progressive infantile/childhood neurodegeneration with cardiomyopathy), and disease severity tracks with the RNase P/tRNA-processing and mitochondrial-integrity defect rather than with residual dehydrogenase activity.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004303
estradiol 17-beta-dehydrogenase [NAD(P)+] activity
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically inferred 17-beta-estradiol dehydrogenase activity. This is a real but weak intrinsic in-vitro activity of HSD17B10 (its k_cat for 17-beta-oestradiol is orders of magnitude below the 3-hydroxyacyl-CoA activity), not its physiological core function. Kept as a valid but non-core side activity.
Reason: Confirmed intrinsic activity but of low catalytic efficiency and not the evolved core function; the steroid activities are minor relative to 3-hydroxyacyl-CoA/MHBD chemistry.
Supporting Evidence:
PMID:10600649
The k(cat) of the ADH activity was three orders of magnitude less than the l-3-hydroxyacyl-CoA dehydrogenase activity but was comparable with that of the enzyme's hydroxysteroid dehydrogenase (HSD) activity for oxidizing 17beta-oestradiol
|
|
GO:0005739
mitochondrion
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic inference of mitochondrial localization, consistent with all experimental data placing HSD17B10 in the mitochondrion (matrix/nucleoid).
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
SUBCELLULAR LOCATION: Mitochondrion
|
|
GO:0006631
fatty acid metabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Broad fatty-acid metabolic process, phylogenetically inferred. HSD17B10 does act as a (S)-3-hydroxyacyl-CoA dehydrogenase, but the more specific and better supported process annotations are fatty acid beta-oxidation and isoleucine catabolism. Kept as a correct but general, non-core parent.
Reason: Correct but too general; more specific child processes (beta-oxidation, isoleucine catabolism) are separately annotated.
|
|
GO:0008209
androgen metabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Androgen metabolic process inferred phylogenetically. Reflects the weak in-vitro testosterone/androstanediol dehydrogenase side activities; not a demonstrated physiological role. Kept as non-core.
Reason: Minor in-vitro steroid side activity, not the evolved core function.
|
|
GO:0008210
estrogen metabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Estrogen metabolic process inferred phylogenetically; reflects weak in-vitro 17-beta-estradiol dehydrogenase side activity. Kept as non-core.
Reason: Minor in-vitro steroid side activity, not the evolved core function.
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (Rhea/EC 1.1.1.35) assignment of (3S)-3-hydroxyacyl-CoA dehydrogenase activity. This is a genuine, well-established core catalytic activity of HSD17B10, independently supported by multiple experimental annotations below. Accept.
Supporting Evidence:
PMID:9553139
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers.
|
|
GO:0004022
alcohol dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
MARK AS OVER ANNOTATED |
Summary: Generic alcohol dehydrogenase (NAD+) activity assigned electronically from Rhea corticosteroid/steroid reactions. HSD17B10 does have a very weak intrinsic alcohol dehydrogenase activity (e.g. on 2-propanol), but this broad term is an over-annotation of what is really a hydroxysteroid/hydroxyacyl-CoA dehydrogenase; the generic parent is uninformative for this gene.
Reason: Over-broad electronic term; the real chemistry is hydroxysteroid/hydroxyacyl-CoA dehydrogenation and the generic ADH activity is trivial and misleading.
Supporting Evidence:
PMID:10600649
The k(cat) of the ADH activity was three orders of magnitude less than the l-3-hydroxyacyl-CoA dehydrogenase activity
|
|
GO:0004303
estradiol 17-beta-dehydrogenase [NAD(P)+] activity
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: Electronic (Rhea/EC 1.1.1.62) assignment of 17-beta-estradiol dehydrogenase activity. Real but weak intrinsic side activity; kept as non-core (see the corresponding experimental annotations).
Reason: Minor in-vitro steroid side activity, not the evolved core function.
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic mitochondrial localization, consistent with all experimental data.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
SUBCELLULAR LOCATION: Mitochondrion
|
|
GO:0008709
cholate 7-alpha-dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: Electronic (Rhea/EC 1.1.1.159) assignment of cholate 7-alpha-dehydrogenase activity, matching the in-vitro bile-acid activity characterized for the human enzyme. Real but non-core (in-vitro bile-acid metabolism).
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
|
|
GO:0016509
long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
MARK AS OVER ANNOTATED |
Summary: Electronic (Rhea:31159, hydroxyhexadecanoyl-CoA) assignment of LONG-chain 3-hydroxyacyl-CoA dehydrogenase activity. HSD17B10 actually PREFERS short- and medium-chain substrates and is a poor long-chain enzyme; this specific long-chain child term over-states its chain-length specificity.
Reason: HSD17B10 preferentially accepts straight medium- and short-chain acyl-CoA; the long-chain-specific term misrepresents its substrate preference.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Preferentially accepts straight medium- and short-chain acyl-CoA substrates
|
|
GO:0042645
mitochondrial nucleoid
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic (UniProt SubCell) mitochondrial-nucleoid localization, supported experimentally: HSD17B10 (as part of the RNase P machinery) associates with mtDNA nucleoids to initiate RNA processing.
Supporting Evidence:
PMID:24703694
mitochondrial RNA processing enzymes involved in tRNA excision, ribonuclease P (RNase P) and ELAC2, as well as a subset of nascent mitochondrial ribosomal proteins (MRPs) associate with nucleoids to initiate RNA processing and ribosome assembly
|
|
GO:0044594
17-beta-hydroxysteroid dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
KEEP AS NON CORE |
Summary: Electronic (Rhea:41992) assignment of 17-beta-hydroxysteroid dehydrogenase activity; corresponds to the enzyme's name-giving but catalytically weak steroid side activity. Kept as non-core.
Reason: Minor in-vitro steroid side activity, not the evolved core function.
|
|
GO:0047015
3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (Rhea:13281/EC 1.1.1.178) assignment of 2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity. This is the physiologically most important catalytic activity of HSD17B10 (isoleucine catabolism) and is strongly supported experimentally. Accept as a core molecular function.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Reaction=(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD(+) = 2-methyl-3-
|
|
GO:0047035
testosterone dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: Electronic (Rhea:14929/EC 1.1.1.239) assignment of testosterone dehydrogenase activity; a demonstrated in-vitro steroid side activity (see IDA below). Kept as non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
|
|
GO:0047044
androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: Electronic (Rhea:42004/EC 1.1.1.53) assignment of androstanediol dehydrogenase activity, matching the in-vitro 3-alpha-hydroxysteroid activity. Non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
|
|
GO:0106281
chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
KEEP AS NON CORE |
Summary: Electronic (Rhea:42036) bile-acid 7-alpha-dehydrogenase activity, also supported by IDA (PMID:12917011). Real but non-core in-vitro bile-acid activity.
Reason: In-vitro bile-acid side activity, not the evolved core function.
|
|
GO:0106282
isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
KEEP AS NON CORE |
Summary: Electronic (Rhea:42024) bile-acid 7-beta-dehydrogenase activity, supported by IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
Reason: In-vitro bile-acid side activity, not the evolved core function.
|
|
GO:0106283
ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
KEEP AS NON CORE |
Summary: Electronic (Rhea:42028) bile-acid 7-beta-dehydrogenase activity, supported by IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
Reason: In-vitro bile-acid side activity, not the evolved core function.
|
|
GO:0005515
protein binding
|
IPI
PMID:18984158 RNase P without RNA: identification and functional reconstit... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRMT10C (Q7L0Y3), from the study that identified HSD17B10/MRPP2 as a mitochondrial RNase P subunit. The interaction is real and biologically central (MRPP1-MRPP2 subcomplex), but the bare "protein binding" term is uninformative; the functional consequence is captured by the RNase P complex / tRNA-processing annotations.
Reason: Uninformative generic protein-binding term; the meaningful TRMT10C interaction is captured by the mitochondrial RNase P complex and tRNA-processing annotations.
Supporting Evidence:
PMID:18984158
composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase- family member, and a protein of hitherto unknown functional and evolutionary origin
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from a large-scale interactome study. Bare "protein binding" is uninformative; functional meaning captured elsewhere.
Reason: Uninformative generic protein-binding term.
|
|
GO:0005515
protein binding
|
IPI
PMID:29128334 A Map of Human Mitochondrial Protein Interactions Linked to ... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to EEF2 (P13639) from a mitochondrial neurodegeneration interactome map. Bare "protein binding" is uninformative and this interaction has no established functional role for HSD17B10.
Reason: Uninformative generic protein-binding term; interaction of unclear significance.
|
|
GO:0005515
protein binding
|
IPI
PMID:29128334 A Map of Human Mitochondrial Protein Interactions Linked to ... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRAP1 (Q12931) from a mitochondrial interactome map. Bare "protein binding" is uninformative; no established functional role.
Reason: Uninformative generic protein-binding term; interaction of unclear significance.
|
|
GO:0005515
protein binding
|
IPI
PMID:29880640 Structural insight into the human mitochondrial tRNA purine ... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from the structural study of the MRPP1/MRPP2 complex. Real and central, but bare "protein binding" is uninformative; captured by the RNase P/methyltransferase complex annotations.
Reason: Uninformative generic protein-binding term; the TRMT10C interaction is captured by the complex/process annotations.
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to APP/amyloid-beta (P05067) from a neurodegenerative-disease interactome study. The Aβ interaction (ABAD/ERAB) is a real disease-association but is non-core; the bare term is uninformative.
Reason: Uninformative generic protein-binding term; Aβ interaction is a disease association, not a core function.
|
|
GO:0005515
protein binding
|
IPI
PMID:32825572 Study of Biomolecular Interactions of Mitochondrial Proteins... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to APP/amyloid-beta processed peptide (P05067-PRO_0000000092) from a study of Alzheimer-related mitochondrial protein interactions. Non-core disease association; bare term uninformative.
Reason: Uninformative generic protein-binding term; Aβ interaction is a disease association, not a core function.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from a proteome-scale interactome study. Bare "protein binding" uninformative; functional meaning captured elsewhere.
Reason: Uninformative generic protein-binding term.
|
|
GO:0005515
protein binding
|
IPI
PMID:9338779 An intracellular protein that binds amyloid-beta peptide and... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to APP/amyloid-beta (P05067) from the original ERAB/Aβ discovery paper. Real disease-association interaction but non-core; the bare term is uninformative.
Reason: Uninformative generic protein-binding term; Aβ interaction is a disease association, not a core function.
|
|
GO:0006550
L-isoleucine catabolic process
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: Electronic (UniPathway) assignment of L-isoleucine catabolism, the pathway in which HSD17B10's MHBD activity acts. Strongly supported experimentally (see IDA annotations). Core biological process.
Supporting Evidence:
PMID:20077426
the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) involved in isoleucine metabolism
|
|
GO:0006635
fatty acid beta-oxidation
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: Electronic (UniPathway) assignment of fatty acid beta-oxidation, where HSD17B10 acts as a short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase (third step of the cycle). Supported by IDA (PMID:12917011). Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
|
|
GO:0006699
bile acid biosynthetic process
|
IEA
GO_REF:0000041 |
KEEP AS NON CORE |
Summary: Electronic (UniPathway) assignment of bile-acid metabolism, reflecting the in-vitro bile-acid (7-alpha/7-beta-hydroxy) dehydrogenase activities. A real but in-vitro, non-core role. Kept as non-core.
Reason: Based on in-vitro bile-acid dehydrogenase activities; physiological contribution to bile-acid biosynthesis is not established.
|
|
GO:0160241
cardiolipin dehydrogenase (NAD+) activity
|
IDA
PMID:26338420 Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are car... |
KEEP AS NON CORE |
Summary: IDA for a phospholipase C-like / cardiolipin-oxidizing activity, with a preference for cardiolipin bearing oxidized fatty acids, proposed to protect against reactive oxygen species. Experimentally supported in vitro but a distinct, non-core moonlighting activity. Keep as non-core.
Reason: Experimentally supported in-vitro activity but a separate moonlighting role, not the evolved core (isoleucine/tRNA) functions.
Supporting Evidence:
PMID:26338420
HSD10 exhibits a strong preference for cardiolipin with oxidized fatty acids.
|
|
GO:0047035
testosterone dehydrogenase (NAD+) activity
|
IDA
PMID:28888424 Novel patient missense mutations in the HSD17B10 gene affect... |
KEEP AS NON CORE |
Summary: IDA testosterone dehydrogenase activity from biochemical characterization of the recombinant enzyme. A demonstrated in-vitro steroid side activity; kept as non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
|
|
GO:0001680
tRNA 3'-terminal CCA addition
|
IDA
PMID:38824131 Structural basis for human mitochondrial tRNA maturation. |
KEEP AS NON CORE |
Summary: IDA (ComplexPortal) involvement in 3'-CCA addition: cryo-EM shows the TRMT10C/SDR5C1 maturation platform retains the tRNA and presents it to the CCA-adding enzyme TRNT1. HSD17B10 participates as part of the platform rather than catalyzing CCA addition itself. Accept as a valid (non-core) process role.
Reason: Real platform role in CCA addition, but ancillary to the core 5'-processing/ RNase P function; HSD17B10 does not itself add CCA.
Supporting Evidence:
PMID:29040705
presents the nascent tRNA to the mitochondrial CCA-adding enzyme
|
|
GO:0005739
mitochondrion
|
NAS
PMID:21593607 Involvement of human ELAC2 gene product in 3' end processing... |
ACCEPT |
Summary: NAS mitochondrial localization; consistent with all experimental evidence.
|
|
GO:0042780
tRNA 3'-end processing
|
IDA
PMID:39516281 Structural basis of 3'-tRNA maturation by the human mitochon... |
KEEP AS NON CORE |
Summary: IDA (ComplexPortal) involvement in tRNA 3'-end processing: cryo-EM of the mitochondrial RNase Z complex (ELAC2/SDR5C1/TRMT10C) shows the SDR5C1/TRMT10C platform supports ELAC2-catalyzed 3'-processing. A real, platform-associated role; kept as non-core relative to the 5'-processing core.
Reason: Platform-supported 3'-processing role; ancillary to the core RNase P 5'-processing function.
Supporting Evidence:
PMID:29040705
significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17 of the 22 tRNAs
|
|
GO:1902494
catalytic complex
|
IPI
PMID:38824131 Structural basis for human mitochondrial tRNA maturation. |
KEEP AS NON CORE |
Summary: Part_of a catalytic complex (ComplexPortal), a generic parent of the mitochondrial RNase P / tRNA-maturation complexes HSD17B10 belongs to. Correct but very general; more specific complex terms (mitochondrial ribonuclease P complex, endoribonuclease complex) are separately annotated.
Reason: Correct but over-general complex term; superseded by specific mitochondrial RNase P complex annotations.
|
|
GO:1902555
endoribonuclease complex
|
IDA
PMID:39516281 Structural basis of 3'-tRNA maturation by the human mitochon... |
KEEP AS NON CORE |
Summary: IDA part_of an endoribonuclease complex (the mitochondrial RNase Z / ELAC2-SDR5C1-TRMT10C complex from cryo-EM). Correct but general; the specific mitochondrial RNase P complex term is the core CC.
Reason: Correct but general complex term; the specific mitochondrial RNase P complex is the core cellular component.
Supporting Evidence:
PMID:39516281
cryo-EM structures of the mitochondrial RNase Z complex (ELAC2/SDR5C1/TRMT10C)
|
|
GO:0005739
mitochondrion
|
IDA
PMID:29880640 Structural insight into the human mitochondrial tRNA purine ... |
ACCEPT |
Summary: IDA mitochondrial localization from the RNase P structural study. Accept.
|
|
GO:0030678
mitochondrial ribonuclease P complex
|
IPI
PMID:29880640 Structural insight into the human mitochondrial tRNA purine ... |
ACCEPT |
Summary: Part_of the mitochondrial RNase P complex, from structural characterization of the MRPP1/MRPP2 (and RNase P) complexes. This is a core cellular component for HSD17B10/MRPP2. Accept.
Supporting Evidence:
PMID:29040705
The human mitochondrial RNase P is composed of three protein subunits: mitochondrial RNase P proteins 1, 2 and 3 (MRPP1, MRPP2 and MRPP3, respectively)
|
|
GO:0097745
mitochondrial tRNA 5'-end processing
|
IDA
PMID:29880640 Structural insight into the human mitochondrial tRNA purine ... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA 5'-end processing, the core RNase P function of HSD17B10/MRPP2. Accept as a core biological process.
Supporting Evidence:
PMID:18984158
extra nucleotides at their 5' ends are removed by an endonuclease called RNase P
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
EXP
PMID:10600649 Intrinsic alcohol dehydrogenase and hydroxysteroid dehydroge... |
ACCEPT |
Summary: EXP (3S)-3-hydroxyacyl-CoA dehydrogenase activity, kinetically characterized on the purified enzyme. Core catalytic activity. Accept.
Supporting Evidence:
PMID:10600649
The k(cat) of the ADH activity was three orders of magnitude less than the l-3-hydroxyacyl-CoA dehydrogenase activity
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
EXP
PMID:26950678 A novel HSD17B10 mutation impairing the activities of the mi... |
ACCEPT |
Summary: EXP 3-hydroxyacyl-CoA dehydrogenase activity, assayed together with RNase P activities for the K212E disease mutant. Core catalytic activity. Accept.
Supporting Evidence:
PMID:26950678
the p.K212E mutation impairs the SDR5C1-dependent mitochondrial RNase P activities
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
EXP
PMID:9553139 A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is id... |
ACCEPT |
Summary: EXP 3-hydroxyacyl-CoA dehydrogenase activity from cloning/characterization of the purified human brain enzyme. Core catalytic activity. Accept.
Supporting Evidence:
PMID:9553139
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers.
|
|
GO:0004303
estradiol 17-beta-dehydrogenase [NAD(P)+] activity
|
EXP
PMID:10600649 Intrinsic alcohol dehydrogenase and hydroxysteroid dehydroge... |
KEEP AS NON CORE |
Summary: EXP 17-beta-estradiol dehydrogenase activity, kinetically characterized. Real but weak intrinsic steroid activity; kept as non-core.
Reason: Weak in-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:10600649
comparable with that of the enzyme's hydroxysteroid dehydrogenase (HSD) activity for oxidizing 17beta-oestradiol
|
|
GO:0004303
estradiol 17-beta-dehydrogenase [NAD(P)+] activity
|
EXP
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: EXP 17-beta-estradiol/hydroxysteroid dehydrogenase activity from the expanded substrate screen. Weak in-vitro steroid activity; non-core.
Reason: Weak in-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
|
|
GO:0005739
mitochondrion
|
EXP
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
ACCEPT |
Summary: EXP mitochondrial localization by confocal/electron microscopy; the human enzyme carries an N-terminal mitochondrial targeting signal. Accept.
Supporting Evidence:
PMID:12917011
the human form is localized to mitochondria
|
|
GO:0005739
mitochondrion
|
EXP
PMID:18984158 RNase P without RNA: identification and functional reconstit... |
ACCEPT |
Summary: EXP mitochondrial localization from the RNase P identification study. Accept.
|
|
GO:0047015
3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
|
EXP
PMID:20077426 A non-enzymatic function of 17beta-hydroxysteroid dehydrogen... |
ACCEPT |
Summary: EXP 2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity, measured with the substrate 2-methyl-3-hydroxybutyryl-CoA on WT and disease-mutant enzymes. Core physiological catalytic activity (isoleucine catabolism). Accept.
Supporting Evidence:
PMID:20077426
substrate 2-methyl-3-hydroxybutyryl-CoA
|
|
GO:0005739
mitochondrion
|
IDA
PMID:23042678 A subcomplex of human mitochondrial RNase P is a bifunctiona... |
ACCEPT |
Summary: IDA mitochondrial localization. Accept.
|
|
GO:0043527
tRNA methyltransferase complex
|
IPI
PMID:23042678 A subcomplex of human mitochondrial RNase P is a bifunctiona... |
ACCEPT |
Summary: Part_of a tRNA methyltransferase complex: the MRPP1-MRPP2 (TRMT10C-SDR5C1) subcomplex is the m1A9/m1G9 methyltransferase, with HSD17B10 as the required non-catalytic partner. Accept as a valid cellular component (methyltransferase subcomplex of RNase P).
Supporting Evidence:
PMID:23042678
the human mitochondrial enzyme, moreover, requires a short-chain dehydrogenase as a partner protein
|
|
GO:0070901
mitochondrial tRNA methylation
|
IDA
PMID:23042678 A subcomplex of human mitochondrial RNase P is a bifunctiona... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9 formation by the MRPP1-MRPP2 subcomplex). A genuine, experimentally supported role of the RNase P machinery HSD17B10 is part of. Accept.
Supporting Evidence:
PMID:23042678
is the methyltransferase responsible for m(1)G9 and m(1)A9 formation
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: HTP mitochondrial localization from a high-confidence mitochondrial proteome study. Consistent with all evidence. Accept.
|
|
GO:0106281
chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA bile-acid 7-alpha-dehydrogenase activity (chenodeoxycholate/cholate) from the expanded substrate screen. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
|
|
GO:0106282
isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA bile-acid 7-beta-dehydrogenase activity on (iso)ursodeoxycholic acid from the substrate screen. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
|
|
GO:0106283
ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA bile-acid 7-beta-dehydrogenase activity on ursodeoxycholic acid. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
|
|
GO:0006550
L-isoleucine catabolic process
|
IDA
PMID:18996107 Study of patients and carriers with 2-methyl-3-hydroxybutyry... |
ACCEPT |
Summary: IDA involvement in L-isoleucine catabolism from clinical/biochemical study of MHBD-deficient patients (deficient MHBD activity, isoleucine-pathway metabolites). Core biological process. Accept.
Supporting Evidence:
PMID:18996107
2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency
|
|
GO:0006550
L-isoleucine catabolic process
|
IDA
PMID:19706438 Mental retardation linked to mutations in the HSD17B10 gene ... |
ACCEPT |
Summary: IDA involvement in isoleucine catabolism; the disease mutant fails to dehydrogenate 2-methyl-3-hydroxybutyryl-CoA. Core biological process. Accept.
Supporting Evidence:
PMID:19706438
HSD10(E249Q) was unable to catalyze the dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA
|
|
GO:0044594
17-beta-hydroxysteroid dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA 17-beta-hydroxysteroid dehydrogenase activity from the expanded substrate screen. Real but weak intrinsic steroid activity; non-core.
Reason: Weak in-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
|
|
GO:0047015
3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
|
IDA
PMID:18996107 Study of patients and carriers with 2-methyl-3-hydroxybutyry... |
ACCEPT |
Summary: IDA MHBD activity measured in patient fibroblasts. Core physiological catalytic activity (isoleucine catabolism). Accept.
Supporting Evidence:
PMID:18996107
MHBD activity was clearly deficient in males
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
ACCEPT |
Summary: IDA (3S)-3-hydroxyacyl-CoA dehydrogenase activity from the substrate screen. Core catalytic activity. Accept.
Supporting Evidence:
PMID:12917011
In addition to the known hydroxyacyl-CoA dehydrogenase
|
|
GO:0006635
fatty acid beta-oxidation
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
ACCEPT |
Summary: IDA involvement in fatty acid beta-oxidation (short/medium-chain 3-hydroxyacyl-CoA dehydrogenase step). Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
|
|
GO:0006699
bile acid biosynthetic process
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA involvement in bile-acid metabolism, from the in-vitro bile-acid dehydrogenase activities and bile-acid isomerization proposal. Real but in-vitro; physiological contribution unestablished. Non-core.
Reason: Based on in-vitro bile-acid activities; physiological role in bile-acid biosynthesis not established.
Supporting Evidence:
PMID:12917011
participates in bile acid isomerization
|
|
GO:0008207
C21-steroid hormone metabolic process
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA involvement in C21-steroid (glucocorticoid/gestagen) metabolism, from the 20-beta/21-OH oxidation activities. In-vitro steroid metabolism; non-core.
Reason: In-vitro steroid metabolism, not the evolved core function.
Supporting Evidence:
PMID:12917011
oxidize the 20beta-OH and 21-OH groups in C21 steroids
|
|
GO:0008209
androgen metabolic process
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA involvement in androgen metabolism, from testosterone/androstanediol dehydrogenase activities. In-vitro steroid metabolism; non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
|
|
GO:0008210
estrogen metabolic process
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA involvement in estrogen metabolism, from 17-beta-estradiol dehydrogenase activity. In-vitro steroid metabolism; non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
17beta-OH activities with sex steroids
|
|
GO:0008709
cholate 7-alpha-dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA cholate 7-alpha-dehydrogenase activity from the substrate screen. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
|
|
GO:0042645
mitochondrial nucleoid
|
IDA
PMID:24703694 Initial steps in RNA processing and ribosome assembly occur ... |
ACCEPT |
Summary: IDA localization to the mitochondrial nucleoid, where RNase P/ELAC2 initiate tRNA processing and ribosome assembly. Accept.
Supporting Evidence:
PMID:24703694
associate with nucleoids to initiate RNA processing and ribosome assembly
|
|
GO:0047015
3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
|
IDA
PMID:19706438 Mental retardation linked to mutations in the HSD17B10 gene ... |
ACCEPT |
Summary: IDA MHBD activity; disease mutant loses dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA. Core physiological catalytic activity. Accept.
Supporting Evidence:
PMID:19706438
HSD10(E249Q) was unable to catalyze the dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA
|
|
GO:0047035
testosterone dehydrogenase (NAD+) activity
|
IDA
PMID:12917011 Expanded substrate screenings of human and Drosophila type 1... |
KEEP AS NON CORE |
Summary: IDA testosterone dehydrogenase activity from the substrate screen. In-vitro steroid side activity; non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
|
|
GO:0062173
brexanolone metabolic process
|
IDA
PMID:19706438 Mental retardation linked to mutations in the HSD17B10 gene ... |
KEEP AS NON CORE |
Summary: IDA involvement in brexanolone (allopregnanolone) metabolism: HSD17B10 oxidizes the 3-alpha-OH of this neurosteroid GABA-A modulator, and disease mutants lose this activity. A genuine, potentially neurologically relevant side activity; kept as non-core relative to the isoleucine/tRNA core roles.
Reason: Real neurosteroid activity of possible pathophysiological relevance, but a side activity rather than the evolved core function.
Supporting Evidence:
PMID:19706438
the oxidation of allopregnanolone, a positive modulator of the gamma-aminobutyric acid type A receptor
|
|
GO:0000049
tRNA binding
|
IDA
PMID:29040705 The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum... |
ACCEPT |
Summary: IDA tRNA binding: the MRPP1/2 (TRMT10C/SDR5C1) complex binds and retains mitochondrial pre-tRNA throughout maturation. tRNA binding is the subunit-level molecular activity underlying HSD17B10/MRPP2's structural role in RNase P/tRNA processing. Accept as a core molecular function.
Supporting Evidence:
PMID:29040705
it retains the tRNA product from the 5'-processing step
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IDA
PMID:25925575 Molecular insights into HSD10 disease: impact of SDR5C1 muta... |
ACCEPT |
Summary: IDA 3-hydroxyacyl-CoA dehydrogenase activity assayed for disease mutants alongside RNase P/tRNA functions. Core catalytic activity. Accept.
Supporting Evidence:
PMID:25925575
pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing and methylation
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IDA
PMID:28888424 Novel patient missense mutations in the HSD17B10 gene affect... |
ACCEPT |
Summary: IDA 3-hydroxyacyl-CoA dehydrogenase activity for the V12L/V176M disease mutants (reduced dehydrogenase activity). Core catalytic activity. Accept.
Supporting Evidence:
PMID:28888424
Both mutant proteins showed significant reduction in the dehydrogenase, methyltransferase and tRNA processing activities compared to wildtype
|
|
GO:0005515
protein binding
|
IPI
PMID:29040705 The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from the MRPP1/2 tRNA-maturation platform study. Real and central, but bare "protein binding" is uninformative; functional meaning captured by the RNase P complex/process annotations.
Reason: Uninformative generic protein-binding term; TRMT10C interaction captured by complex/process annotations.
|
|
GO:0030678
mitochondrial ribonuclease P complex
|
IDA
PMID:25925575 Molecular insights into HSD10 disease: impact of SDR5C1 muta... |
ACCEPT |
Summary: IDA part_of the mitochondrial RNase P complex; disease mutations disrupt complex assembly/interaction with TRMT10C. Core cellular component. Accept.
Supporting Evidence:
PMID:25925575
moonlighting as a component of human mitochondrial RNase P
|
|
GO:0030678
mitochondrial ribonuclease P complex
|
IDA
PMID:28888424 Novel patient missense mutations in the HSD17B10 gene affect... |
ACCEPT |
Summary: IDA part_of the mitochondrial RNase P complex (MRPP1/MRPP2/MRPP3). Core cellular component. Accept.
Supporting Evidence:
PMID:28888424
in a complex with MRPP1 and MRPP3 (also known as PRORP) proteins for 5'-end processing of mitochondrial precursor tRNA
|
|
GO:0051289
protein homotetramerization
|
IDA
PMID:25925575 Molecular insights into HSD10 disease: impact of SDR5C1 muta... |
ACCEPT |
Summary: IDA protein homotetramerization; HSD17B10 functions as a homotetramer and some disease mutations disrupt tetramerization. A genuine, structurally important property. Accept.
Supporting Evidence:
PMID:25925575
Some mutations disrupt the homotetramerization of SDR5C1
|
|
GO:0070901
mitochondrial tRNA methylation
|
IDA
PMID:25925575 Molecular insights into HSD10 disease: impact of SDR5C1 muta... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9); disease mutations impair methylation. Genuine RNase P subcomplex role. Accept.
Supporting Evidence:
PMID:25925575
pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing and methylation
|
|
GO:0070901
mitochondrial tRNA methylation
|
IDA
PMID:28888424 Novel patient missense mutations in the HSD17B10 gene affect... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA methylation; V12L/V176M mutants show reduced methyltransferase activity. Accept.
Supporting Evidence:
PMID:28888424
N1-methylation of purines at position 9 of mitochondrial tRNA
|
|
GO:0097745
mitochondrial tRNA 5'-end processing
|
IDA
PMID:24549042 Mutation or knock-down of 17β-hydroxysteroid dehydrogenase t... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; knock-down / patient mutation impairs heavy-strand transcript processing. Core biological process. Accept.
Supporting Evidence:
PMID:24549042
evidence of impaired processing of precursor tRNA transcripts of the mitochondrial heavy strand
|
|
GO:0097745
mitochondrial tRNA 5'-end processing
|
IDA
PMID:25925575 Molecular insights into HSD10 disease: impact of SDR5C1 muta... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; disease mutations impair RNase P tRNA processing. Core biological process. Accept.
Supporting Evidence:
PMID:25925575
the enzyme removing 5'-extensions of tRNAs, an early and crucial step in tRNA maturation
|
|
GO:0097745
mitochondrial tRNA 5'-end processing
|
IDA
PMID:28888424 Novel patient missense mutations in the HSD17B10 gene affect... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; disease mutants show reduced tRNA processing. Core biological process. Accept.
Supporting Evidence:
PMID:28888424
5'-end processing of mitochondrial precursor tRNA
|
|
GO:0097745
mitochondrial tRNA 5'-end processing
|
IDA
PMID:29040705 The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum... |
ACCEPT |
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; MRPP1/2 mediates RNase P 5'-leader removal. Core biological process. Accept.
Supporting Evidence:
PMID:29040705
MRPP1/2 is not only responsible for mitochondrial RNase P-based 5'-leader removal
|
|
GO:1990180
mitochondrial tRNA 3'-end processing
|
IDA
PMID:29040705 The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum... |
KEEP AS NON CORE |
Summary: IDA involvement in mitochondrial tRNA 3'-end processing: the MRPP1/2 platform retains the tRNA after 5'-cleavage and enhances ELAC2-catalyzed 3'-processing. Real platform-associated role; kept as non-core relative to the 5'-processing core (HSD17B10 does not itself perform 3'-cleavage).
Reason: Platform-supported 3'-processing role; ancillary to the core RNase P 5'-processing function.
Supporting Evidence:
PMID:29040705
significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17 of the 22 tRNAs
|
|
GO:0007005
mitochondrion organization
|
IMP
PMID:20077426 A non-enzymatic function of 17beta-hydroxysteroid dehydrogen... |
KEEP AS NON CORE |
Summary: IMP involvement in mitochondrion organization: knock-down/knock-out and disease mutations disrupt mitochondrial structural integrity (cristae) independently of dehydrogenase activity. This reflects the essential non-enzymatic (RNase P/tRNA-processing) role. A genuine but downstream/pleiotropic process; kept as non-core.
Reason: Genuine IMP phenotype but a downstream consequence of the RNase P/tRNA-processing role; more specific molecular roles capture the core function.
Supporting Evidence:
PMID:20077426
a property of HSD10 independent of its enzymatic activity is essential for structural and functional integrity of mitochondria
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IDA
PMID:23042678 A subcomplex of human mitochondrial RNase P is a bifunctiona... |
ACCEPT |
Summary: IDA 3-hydroxyacyl-CoA dehydrogenase activity (CAFA-assigned) associated with the methyltransferase-subcomplex study. Core catalytic activity. Accept.
Supporting Evidence:
PMID:23042678
a fatty and amino acid degradation enzyme in tRNA methylation
|
|
GO:0005515
protein binding
|
IPI
PMID:23042678 A subcomplex of human mitochondrial RNase P is a bifunctiona... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding to TRMT10C (Q7L0Y3), the methyltransferase partner. Real and central, but bare "protein binding" is uninformative; captured by the RNase P / methyltransferase complex annotations.
Reason: Uninformative generic protein-binding term; TRMT10C interaction captured by complex annotations.
|
|
GO:0030678
mitochondrial ribonuclease P complex
|
TAS
PMID:23042678 A subcomplex of human mitochondrial RNase P is a bifunctiona... |
ACCEPT |
Summary: TAS part_of the mitochondrial RNase P complex. Core cellular component, independently supported by IDA. Accept.
Supporting Evidence:
PMID:23042678
a subcomplex of human mitochondrial RNase P
|
|
GO:0003723
RNA binding
|
HDA
PMID:22681889 The mRNA-bound proteome and its global occupancy profile on ... |
MARK AS OVER ANNOTATED |
Summary: HDA RNA binding from a global mRNA-interactome capture screen. HSD17B10 does bind tRNA (specifically captured by GO:0000049), but this high-throughput generic "RNA binding" from a poly(A)-mRNA capture experiment is a non-specific over-annotation for a protein whose relevant RNA ligand is tRNA.
Reason: Non-specific high-throughput RNA-binding capture; the specific and relevant activity (tRNA binding) is separately and better annotated.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-508369 |
ACCEPT |
Summary: TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism reaction. Consistent with the authoritative matrix localization. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-6787591 |
ACCEPT |
Summary: TAS (Reactome) mitochondrial-matrix localization for the tRNA m1G9 methylation reaction. Consistent with authoritative matrix localization. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-6787594 |
ACCEPT |
Summary: TAS (Reactome) mitochondrial-matrix localization for the tRNA m1A9 methylation reaction. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-70837 |
ACCEPT |
Summary: TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism (MHBD) reaction. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9838081 |
ACCEPT |
Summary: TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein degradation context). Localization consistent with authoritative matrix localization. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9838093 |
ACCEPT |
Summary: TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein binding context). Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
|
|
GO:0005739
mitochondrion
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS mitochondrial localization by orthology to mouse (O08756). Consistent with all experimental data. Accept.
|
|
GO:0005737
cytoplasm
|
TAS
PMID:9338779 An intracellular protein that binds amyloid-beta peptide and... |
MARK AS OVER ANNOTATED |
Summary: TAS cytoplasm from the 1997 ERAB discovery paper, which reported an ER/plasma-membrane-associated Aβ-binding protein. This localization is a legacy mis-assignment superseded by all subsequent work establishing the protein as mitochondrial (matrix/nucleoid). Over-annotated.
Reason: Legacy mislocalization from the original ERAB paper; superseded by mitochondrial matrix/nucleoid localization in all later studies.
Supporting Evidence:
PMID:12917011
the human form is localized to mitochondria
|
|
GO:0005886
plasma membrane
|
TAS
PMID:9338779 An intracellular protein that binds amyloid-beta peptide and... |
MARK AS OVER ANNOTATED |
Summary: TAS plasma membrane from the 1997 ERAB discovery paper. A legacy mis-assignment; the protein is a mitochondrial-matrix enzyme with no established plasma-membrane role. Over-annotated.
Reason: Legacy mislocalization from the original ERAB paper; superseded by mitochondrial localization.
Supporting Evidence:
PMID:12917011
the human form is localized to mitochondria
|
|
GO:0006629
lipid metabolic process
|
TAS
PMID:9338779 An intracellular protein that binds amyloid-beta peptide and... |
KEEP AS NON CORE |
Summary: TAS broad "lipid metabolic process" from the 1997 ERAB paper. HSD17B10 does have fatty-acid/cardiolipin/steroid-lipid activities, so a lipid-metabolism parent is not wrong, but this is a very general term captured better by fatty acid beta-oxidation. Kept as non-core.
Reason: Over-general parent; more specific lipid processes are separately annotated.
|
|
GO:0008709
cholate 7-alpha-dehydrogenase (NAD+) activity
|
TAS
PMID:9338779 An intracellular protein that binds amyloid-beta peptide and... |
KEEP AS NON CORE |
Summary: TAS cholate 7-alpha-dehydrogenase activity attributed to the 1997 ERAB paper, which did NOT establish bile-acid activity (it described an Aβ-binding dehydrogenase); the bile-acid activity was actually characterized later (PMID:12917011, separately annotated by IDA). The activity itself is a real but non-core in-vitro side activity, so this is kept as non-core; note that the 1997 citation is a legacy mis-attribution and the true support is PMID:12917011.
Reason: Real but non-core in-vitro bile-acid side activity; the cited 1997 paper does not actually support it (true support is the later IDA, PMID:12917011).
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
|
Q: Which of HSD17B10's catalytic activities (isoleucine-pathway MHBD, general 3-hydroxyacyl-CoA, neurosteroid/allopregnanolone, cardiolipin phospholipase) are physiologically significant in vivo versus in-vitro artifacts of a broad-specificity SDR active site?
Q: How does the non-catalytic RNase P/tRNA-processing role mechanistically account for HSD10 disease severity, and can it be uncoupled therapeutically from the metabolic (isoleucine) role?
Q: Does the neurosteroid (allopregnanolone/brexanolone) oxidation activity contribute to the neurological phenotype of HSD10 disease independently of tRNA processing?
Experiment: Separation-of-function mutants that selectively abolish either dehydrogenase activity or RNase P/TRMT10C-binding, tested in patient-derived and knockout cells for mitochondrial tRNA processing, respiratory chain assembly, and viability.
Experiment: Quantitative in-vivo metabolic flux analysis of isoleucine catabolism and neurosteroid (allopregnanolone) levels in HSD10-deficient models to define which metabolic defects contribute to neuropathology.
Experiment: Structural and biochemical dissection of how the HSD17B10 homotetramer scaffolds TRMT10C and pre-tRNA across the sequential 5'-processing, methylation, 3'-processing and CCA-addition steps.
Human 17-beta-hydroxysteroid dehydrogenase type 10. UniProt RecName is
"3-hydroxyacyl-CoA dehydrogenase type-2". Aliases: HADH2, MRPP2, SCHAD, SDR5C1,
ERAB, ABAD, XH98G2. HGNC:4800; Gene ID 3028; X-linked (Xp11.22). 261 aa, homotetramer.
HSD17B10 has two distinct, essential roles that are functionally independent
(the disease impairs both):
Also reported as a cardiolipin phospholipase C-like enzyme in vitro
PMID:26338420.
Structural, NON-catalytic moonlighting as MRPP2, an essential subunit of
mitochondrial RNase P (with TRMT10C/MRPP1 and PRORP/MRPP3). This role is
independent of the dehydrogenase activity.
X-linked, progressive neurodegeneration, psychomotor regression, seizures,
cardiomyopathy. Crucially, symptom severity does NOT correlate with residual
dehydrogenase activity — the pathogenic mechanism is loss of the non-enzymatic
mitochondrial (RNase P/tRNA processing, mitochondrial integrity) function
PMID:20077426;
[PMID:25575635 title "Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing"];
PMID:24549042.
Pathogenic missense mutations (e.g. R130C, D86G, Q165H, K212E, P210S, R226Q, N247S,
V12L, V176M, E249Q) impair dehydrogenase AND tRNA methylation/processing
PMID:25925575;
PMID:26950678;
PMID:28888424.
Historically discovered as an intracellular Aβ-binding protein (ERAB/ABAD) that
mediates neurotoxicity; identical to SCHAD
PMID:9553139.
The Aβ (APP) interaction is real but is a disease-association / binding role, not the
protein's evolved core function. Kept as non-core.
Authoritative: mitochondrion / mitochondrial matrix / mitochondrial nucleoid
[file UniProt: "SUBCELLULAR LOCATION: Mitochondrion ... Mitochondrion matrix, mitochondrion nucleoid"].
Older PINC (ProtInc) TAS annotations to cytoplasm and plasma membrane (both
from PMID:9338779, the 1997 ERAB discovery paper that mislabeled it as ER/plasma
membrane) are legacy mislocalizations superseded by all later work; marked
over-annotated (kept, not removed, per experimental-annotation policy, though these
are TAS not EXP).
id: Q99714
gene_symbol: HSD17B10
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
HSD17B10 (also known as HADH2, SCHAD, SDR5C1, MRPP2, and historically ERAB/ABAD)
is a mitochondrial-matrix protein of the short-chain dehydrogenase/reductase (SDR)
family that acts as a functional homotetramer and is a genuinely moonlighting,
multifunctional enzyme. In its catalytic role it is an NAD+-dependent
dehydrogenase whose physiologically important activity is
(S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) in L-isoleucine
catabolism, oxidizing (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to
2-methyl-3-oxobutanoyl-CoA. It has broad (S)-3-hydroxyacyl-CoA dehydrogenase
activity on short/medium straight-chain acyl-CoAs and weaker intrinsic
17-beta-/3-alpha-hydroxysteroid and alcohol dehydrogenase activities toward
steroid hormones (including the neurosteroid allopregnanolone/brexanolone), bile
acids and other substrates. Independently of its enzymatic activity, it moonlights
as MRPP2, an essential non-catalytic subunit of mitochondrial RNase P (together
with the methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3), which
performs 5'-end processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex
additionally catalyzes N1-methylation of purine-9 (m1A9/m1G9) of mt-tRNAs and acts
as a tRNA-maturation platform that supports downstream 3'-processing by ELAC2 and
3'-CCA addition by TRNT1. It localizes to the mitochondrial matrix and associates
with the mitochondrial nucleoid. Loss-of-function mutations in the X-linked
HSD17B10 gene cause HSD10 mitochondrial disease (a progressive infantile/childhood
neurodegeneration with cardiomyopathy), and disease severity tracks with the
RNase P/tRNA-processing and mitochondrial-integrity defect rather than with
residual dehydrogenase activity.
alternative_products:
- name: '1'
id: Q99714-1
- name: '2'
id: Q99714-2
sequence_note: VSP_007830
existing_annotations:
- term:
id: GO:0004303
label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred 17-beta-estradiol dehydrogenase activity. This is a
real but weak intrinsic in-vitro activity of HSD17B10 (its k_cat for
17-beta-oestradiol is orders of magnitude below the 3-hydroxyacyl-CoA
activity), not its physiological core function. Kept as a valid but non-core
side activity.
action: KEEP_AS_NON_CORE
reason: >-
Confirmed intrinsic activity but of low catalytic efficiency and not the
evolved core function; the steroid activities are minor relative to
3-hydroxyacyl-CoA/MHBD chemistry.
supported_by:
- reference_id: PMID:10600649
supporting_text: >-
The k(cat) of the ADH activity was three orders of magnitude less than the
l-3-hydroxyacyl-CoA dehydrogenase activity but was comparable with that of
the enzyme's hydroxysteroid dehydrogenase (HSD) activity for oxidizing
17beta-oestradiol
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetic inference of mitochondrial localization, consistent with all
experimental data placing HSD17B10 in the mitochondrion (matrix/nucleoid).
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Mitochondrion
- term:
id: GO:0006631
label: fatty acid metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Broad fatty-acid metabolic process, phylogenetically inferred. HSD17B10 does
act as a (S)-3-hydroxyacyl-CoA dehydrogenase, but the more specific and better
supported process annotations are fatty acid beta-oxidation and isoleucine
catabolism. Kept as a correct but general, non-core parent.
action: KEEP_AS_NON_CORE
reason: >-
Correct but too general; more specific child processes (beta-oxidation,
isoleucine catabolism) are separately annotated.
- term:
id: GO:0008209
label: androgen metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Androgen metabolic process inferred phylogenetically. Reflects the weak
in-vitro testosterone/androstanediol dehydrogenase side activities; not a
demonstrated physiological role. Kept as non-core.
action: KEEP_AS_NON_CORE
reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0008210
label: estrogen metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Estrogen metabolic process inferred phylogenetically; reflects weak in-vitro
17-beta-estradiol dehydrogenase side activity. Kept as non-core.
action: KEEP_AS_NON_CORE
reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (Rhea/EC 1.1.1.35) assignment of (3S)-3-hydroxyacyl-CoA
dehydrogenase activity. This is a genuine, well-established core catalytic
activity of HSD17B10, independently supported by multiple experimental
annotations below. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:9553139
supporting_text: >-
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
D-isomers.
- term:
id: GO:0004022
label: alcohol dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Generic alcohol dehydrogenase (NAD+) activity assigned electronically from Rhea
corticosteroid/steroid reactions. HSD17B10 does have a very weak intrinsic
alcohol dehydrogenase activity (e.g. on 2-propanol), but this broad term is an
over-annotation of what is really a hydroxysteroid/hydroxyacyl-CoA
dehydrogenase; the generic parent is uninformative for this gene.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Over-broad electronic term; the real chemistry is hydroxysteroid/hydroxyacyl-CoA
dehydrogenation and the generic ADH activity is trivial and misleading.
supported_by:
- reference_id: PMID:10600649
supporting_text: >-
The k(cat) of the ADH activity was three orders of magnitude less than the
l-3-hydroxyacyl-CoA dehydrogenase activity
- term:
id: GO:0004303
label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (Rhea/EC 1.1.1.62) assignment of 17-beta-estradiol dehydrogenase
activity. Real but weak intrinsic side activity; kept as non-core (see the
corresponding experimental annotations).
action: KEEP_AS_NON_CORE
reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: Electronic mitochondrial localization, consistent with all experimental data.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Mitochondrion
- term:
id: GO:0008709
label: cholate 7-alpha-dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (Rhea/EC 1.1.1.159) assignment of cholate 7-alpha-dehydrogenase
activity, matching the in-vitro bile-acid activity characterized for the human
enzyme. Real but non-core (in-vitro bile-acid metabolism).
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
(5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
- term:
id: GO:0016509
label: long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Electronic (Rhea:31159, hydroxyhexadecanoyl-CoA) assignment of LONG-chain
3-hydroxyacyl-CoA dehydrogenase activity. HSD17B10 actually PREFERS short- and
medium-chain substrates and is a poor long-chain enzyme; this specific
long-chain child term over-states its chain-length specificity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
HSD17B10 preferentially accepts straight medium- and short-chain acyl-CoA;
the long-chain-specific term misrepresents its substrate preference.
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Preferentially accepts straight medium- and short-chain acyl-CoA substrates
- term:
id: GO:0042645
label: mitochondrial nucleoid
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic (UniProt SubCell) mitochondrial-nucleoid localization, supported
experimentally: HSD17B10 (as part of the RNase P machinery) associates with
mtDNA nucleoids to initiate RNA processing.
action: ACCEPT
supported_by:
- reference_id: PMID:24703694
supporting_text: >-
mitochondrial RNA processing enzymes involved in tRNA excision, ribonuclease
P (RNase P) and ELAC2, as well as a subset of nascent mitochondrial ribosomal
proteins (MRPs) associate with nucleoids to initiate RNA processing and
ribosome assembly
- term:
id: GO:0044594
label: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Electronic (Rhea:41992) assignment of 17-beta-hydroxysteroid dehydrogenase
activity; corresponds to the enzyme's name-giving but catalytically weak
steroid side activity. Kept as non-core.
action: KEEP_AS_NON_CORE
reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0047015
label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (Rhea:13281/EC 1.1.1.178) assignment of
2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity. This is the
physiologically most important catalytic activity of HSD17B10 (isoleucine
catabolism) and is strongly supported experimentally. Accept as a core
molecular function.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Reaction=(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD(+) = 2-methyl-3-
- term:
id: GO:0047035
label: testosterone dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (Rhea:14929/EC 1.1.1.239) assignment of testosterone dehydrogenase
activity; a demonstrated in-vitro steroid side activity (see IDA below). Kept
as non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0047044
label: androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (Rhea:42004/EC 1.1.1.53) assignment of androstanediol dehydrogenase
activity, matching the in-vitro 3-alpha-hydroxysteroid activity. Non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0106281
label: chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Electronic (Rhea:42036) bile-acid 7-alpha-dehydrogenase activity, also
supported by IDA (PMID:12917011). Real but non-core in-vitro bile-acid activity.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
- term:
id: GO:0106282
label: isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Electronic (Rhea:42024) bile-acid 7-beta-dehydrogenase activity, supported by
IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
- term:
id: GO:0106283
label: ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Electronic (Rhea:42028) bile-acid 7-beta-dehydrogenase activity, supported by
IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18984158
qualifier: enables
review:
summary: >-
IPI protein-binding to TRMT10C (Q7L0Y3), from the study that identified
HSD17B10/MRPP2 as a mitochondrial RNase P subunit. The interaction is real and
biologically central (MRPP1-MRPP2 subcomplex), but the bare "protein binding"
term is uninformative; the functional consequence is captured by the RNase P
complex / tRNA-processing annotations.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; the meaningful TRMT10C interaction
is captured by the mitochondrial RNase P complex and tRNA-processing annotations.
supported_by:
- reference_id: PMID:18984158
supporting_text: >-
composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-
family member, and a protein of hitherto unknown functional and evolutionary
origin
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
IPI protein-binding to TRMT10C (Q7L0Y3) from a large-scale interactome study.
Bare "protein binding" is uninformative; functional meaning captured elsewhere.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic protein-binding term.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29128334
qualifier: enables
review:
summary: >-
IPI protein-binding to EEF2 (P13639) from a mitochondrial neurodegeneration
interactome map. Bare "protein binding" is uninformative and this interaction
has no established functional role for HSD17B10.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic protein-binding term; interaction of unclear significance.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29128334
qualifier: enables
review:
summary: >-
IPI protein-binding to TRAP1 (Q12931) from a mitochondrial interactome map.
Bare "protein binding" is uninformative; no established functional role.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic protein-binding term; interaction of unclear significance.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29880640
qualifier: enables
review:
summary: >-
IPI protein-binding to TRMT10C (Q7L0Y3) from the structural study of the
MRPP1/MRPP2 complex. Real and central, but bare "protein binding" is
uninformative; captured by the RNase P/methyltransferase complex annotations.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; the TRMT10C interaction is captured
by the complex/process annotations.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: >-
IPI protein-binding to APP/amyloid-beta (P05067) from a neurodegenerative-disease
interactome study. The Aβ interaction (ABAD/ERAB) is a real disease-association
but is non-core; the bare term is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; Aβ interaction is a disease
association, not a core function.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32825572
qualifier: enables
review:
summary: >-
IPI protein-binding to APP/amyloid-beta processed peptide
(P05067-PRO_0000000092) from a study of Alzheimer-related mitochondrial protein
interactions. Non-core disease association; bare term uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; Aβ interaction is a disease
association, not a core function.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
IPI protein-binding to TRMT10C (Q7L0Y3) from a proteome-scale interactome study.
Bare "protein binding" uninformative; functional meaning captured elsewhere.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic protein-binding term.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:9338779
qualifier: enables
review:
summary: >-
IPI protein-binding to APP/amyloid-beta (P05067) from the original ERAB/Aβ
discovery paper. Real disease-association interaction but non-core; the bare
term is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; Aβ interaction is a disease
association, not a core function.
- term:
id: GO:0006550
label: L-isoleucine catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
Electronic (UniPathway) assignment of L-isoleucine catabolism, the pathway in
which HSD17B10's MHBD activity acts. Strongly supported experimentally
(see IDA annotations). Core biological process.
action: ACCEPT
supported_by:
- reference_id: PMID:20077426
supporting_text: >-
the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD)
involved in isoleucine metabolism
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
Electronic (UniPathway) assignment of fatty acid beta-oxidation, where
HSD17B10 acts as a short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase
(third step of the cycle). Supported by IDA (PMID:12917011). Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
Electronic (UniPathway) assignment of bile-acid metabolism, reflecting the
in-vitro bile-acid (7-alpha/7-beta-hydroxy) dehydrogenase activities. A real but
in-vitro, non-core role. Kept as non-core.
action: KEEP_AS_NON_CORE
reason: >-
Based on in-vitro bile-acid dehydrogenase activities; physiological
contribution to bile-acid biosynthesis is not established.
- term:
id: GO:0160241
label: cardiolipin dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:26338420
qualifier: enables
review:
summary: >-
IDA for a phospholipase C-like / cardiolipin-oxidizing activity, with a
preference for cardiolipin bearing oxidized fatty acids, proposed to protect
against reactive oxygen species. Experimentally supported in vitro but a
distinct, non-core moonlighting activity. Keep as non-core.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally supported in-vitro activity but a separate moonlighting role,
not the evolved core (isoleucine/tRNA) functions.
supported_by:
- reference_id: PMID:26338420
supporting_text: >-
HSD10 exhibits a strong preference for cardiolipin with oxidized fatty acids.
- term:
id: GO:0047035
label: testosterone dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:28888424
qualifier: enables
review:
summary: >-
IDA testosterone dehydrogenase activity from biochemical characterization of
the recombinant enzyme. A demonstrated in-vitro steroid side activity; kept as
non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid side activity, not the evolved core function.
- term:
id: GO:0001680
label: tRNA 3'-terminal CCA addition
evidence_type: IDA
original_reference_id: PMID:38824131
qualifier: involved_in
review:
summary: >-
IDA (ComplexPortal) involvement in 3'-CCA addition: cryo-EM shows the
TRMT10C/SDR5C1 maturation platform retains the tRNA and presents it to the
CCA-adding enzyme TRNT1. HSD17B10 participates as part of the platform rather
than catalyzing CCA addition itself. Accept as a valid (non-core) process role.
action: KEEP_AS_NON_CORE
reason: >-
Real platform role in CCA addition, but ancillary to the core 5'-processing/
RNase P function; HSD17B10 does not itself add CCA.
supported_by:
- reference_id: PMID:29040705
supporting_text: >-
presents the nascent tRNA to the mitochondrial CCA-adding enzyme
- term:
id: GO:0005739
label: mitochondrion
evidence_type: NAS
original_reference_id: PMID:21593607
qualifier: located_in
review:
summary: NAS mitochondrial localization; consistent with all experimental evidence.
action: ACCEPT
- term:
id: GO:0042780
label: tRNA 3'-end processing
evidence_type: IDA
original_reference_id: PMID:39516281
qualifier: involved_in
review:
summary: >-
IDA (ComplexPortal) involvement in tRNA 3'-end processing: cryo-EM of the
mitochondrial RNase Z complex (ELAC2/SDR5C1/TRMT10C) shows the SDR5C1/TRMT10C
platform supports ELAC2-catalyzed 3'-processing. A real, platform-associated
role; kept as non-core relative to the 5'-processing core.
action: KEEP_AS_NON_CORE
reason: >-
Platform-supported 3'-processing role; ancillary to the core RNase P
5'-processing function.
supported_by:
- reference_id: PMID:29040705
supporting_text: >-
significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17
of the 22 tRNAs
- term:
id: GO:1902494
label: catalytic complex
evidence_type: IPI
original_reference_id: PMID:38824131
qualifier: part_of
review:
summary: >-
Part_of a catalytic complex (ComplexPortal), a generic parent of the
mitochondrial RNase P / tRNA-maturation complexes HSD17B10 belongs to. Correct
but very general; more specific complex terms (mitochondrial ribonuclease P
complex, endoribonuclease complex) are separately annotated.
action: KEEP_AS_NON_CORE
reason: >-
Correct but over-general complex term; superseded by specific mitochondrial
RNase P complex annotations.
- term:
id: GO:1902555
label: endoribonuclease complex
evidence_type: IDA
original_reference_id: PMID:39516281
qualifier: part_of
review:
summary: >-
IDA part_of an endoribonuclease complex (the mitochondrial RNase Z /
ELAC2-SDR5C1-TRMT10C complex from cryo-EM). Correct but general; the specific
mitochondrial RNase P complex term is the core CC.
action: KEEP_AS_NON_CORE
reason: >-
Correct but general complex term; the specific mitochondrial RNase P complex is
the core cellular component.
supported_by:
- reference_id: PMID:39516281
supporting_text: >-
cryo-EM structures of the mitochondrial RNase Z complex
(ELAC2/SDR5C1/TRMT10C)
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:29880640
qualifier: located_in
review:
summary: IDA mitochondrial localization from the RNase P structural study. Accept.
action: ACCEPT
- term:
id: GO:0030678
label: mitochondrial ribonuclease P complex
evidence_type: IPI
original_reference_id: PMID:29880640
qualifier: part_of
review:
summary: >-
Part_of the mitochondrial RNase P complex, from structural characterization of
the MRPP1/MRPP2 (and RNase P) complexes. This is a core cellular component for
HSD17B10/MRPP2. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:29040705
supporting_text: >-
The human mitochondrial RNase P is composed of three protein subunits:
mitochondrial RNase P proteins 1, 2 and 3 (MRPP1, MRPP2 and MRPP3,
respectively)
- term:
id: GO:0097745
label: mitochondrial tRNA 5'-end processing
evidence_type: IDA
original_reference_id: PMID:29880640
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA 5'-end processing, the core RNase P
function of HSD17B10/MRPP2. Accept as a core biological process.
action: ACCEPT
supported_by:
- reference_id: PMID:18984158
supporting_text: >-
extra nucleotides at their 5' ends are removed by an endonuclease called
RNase P
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: EXP
original_reference_id: PMID:10600649
qualifier: enables
review:
summary: >-
EXP (3S)-3-hydroxyacyl-CoA dehydrogenase activity, kinetically characterized on
the purified enzyme. Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:10600649
supporting_text: >-
The k(cat) of the ADH activity was three orders of magnitude less than the
l-3-hydroxyacyl-CoA dehydrogenase activity
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: EXP
original_reference_id: PMID:26950678
qualifier: enables
review:
summary: >-
EXP 3-hydroxyacyl-CoA dehydrogenase activity, assayed together with RNase P
activities for the K212E disease mutant. Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:26950678
supporting_text: >-
the p.K212E mutation impairs the SDR5C1-dependent mitochondrial RNase P
activities
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: EXP
original_reference_id: PMID:9553139
qualifier: enables
review:
summary: >-
EXP 3-hydroxyacyl-CoA dehydrogenase activity from cloning/characterization of
the purified human brain enzyme. Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:9553139
supporting_text: >-
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
D-isomers.
- term:
id: GO:0004303
label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
evidence_type: EXP
original_reference_id: PMID:10600649
qualifier: enables
review:
summary: >-
EXP 17-beta-estradiol dehydrogenase activity, kinetically characterized. Real
but weak intrinsic steroid activity; kept as non-core.
action: KEEP_AS_NON_CORE
reason: Weak in-vitro steroid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:10600649
supporting_text: >-
comparable with that of the enzyme's hydroxysteroid dehydrogenase (HSD)
activity for oxidizing 17beta-oestradiol
- term:
id: GO:0004303
label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
evidence_type: EXP
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
EXP 17-beta-estradiol/hydroxysteroid dehydrogenase activity from the expanded
substrate screen. Weak in-vitro steroid activity; non-core.
action: KEEP_AS_NON_CORE
reason: Weak in-vitro steroid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
3alpha-OH and 17beta-OH activities with sex steroids
- term:
id: GO:0005739
label: mitochondrion
evidence_type: EXP
original_reference_id: PMID:12917011
qualifier: located_in
review:
summary: >-
EXP mitochondrial localization by confocal/electron microscopy; the human
enzyme carries an N-terminal mitochondrial targeting signal. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human form is localized to mitochondria
- term:
id: GO:0005739
label: mitochondrion
evidence_type: EXP
original_reference_id: PMID:18984158
qualifier: located_in
review:
summary: EXP mitochondrial localization from the RNase P identification study. Accept.
action: ACCEPT
- term:
id: GO:0047015
label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
evidence_type: EXP
original_reference_id: PMID:20077426
qualifier: enables
review:
summary: >-
EXP 2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity, measured with
the substrate 2-methyl-3-hydroxybutyryl-CoA on WT and disease-mutant enzymes.
Core physiological catalytic activity (isoleucine catabolism). Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:20077426
supporting_text: >-
substrate 2-methyl-3-hydroxybutyryl-CoA
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:23042678
qualifier: located_in
review:
summary: IDA mitochondrial localization. Accept.
action: ACCEPT
- term:
id: GO:0043527
label: tRNA methyltransferase complex
evidence_type: IPI
original_reference_id: PMID:23042678
qualifier: part_of
review:
summary: >-
Part_of a tRNA methyltransferase complex: the MRPP1-MRPP2 (TRMT10C-SDR5C1)
subcomplex is the m1A9/m1G9 methyltransferase, with HSD17B10 as the required
non-catalytic partner. Accept as a valid cellular component (methyltransferase
subcomplex of RNase P).
action: ACCEPT
supported_by:
- reference_id: PMID:23042678
supporting_text: >-
the human mitochondrial enzyme, moreover, requires a short-chain
dehydrogenase as a partner protein
- term:
id: GO:0070901
label: mitochondrial tRNA methylation
evidence_type: IDA
original_reference_id: PMID:23042678
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9 formation by the
MRPP1-MRPP2 subcomplex). A genuine, experimentally supported role of the RNase P
machinery HSD17B10 is part of. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:23042678
supporting_text: >-
is the methyltransferase responsible for m(1)G9 and m(1)A9 formation
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
HTP mitochondrial localization from a high-confidence mitochondrial proteome
study. Consistent with all evidence. Accept.
action: ACCEPT
- term:
id: GO:0106281
label: chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA bile-acid 7-alpha-dehydrogenase activity (chenodeoxycholate/cholate) from
the expanded substrate screen. Real in-vitro bile-acid activity; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
- term:
id: GO:0106282
label: isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA bile-acid 7-beta-dehydrogenase activity on (iso)ursodeoxycholic acid from
the substrate screen. Real in-vitro bile-acid activity; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
- term:
id: GO:0106283
label: ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA bile-acid 7-beta-dehydrogenase activity on ursodeoxycholic acid. Real
in-vitro bile-acid activity; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
- term:
id: GO:0006550
label: L-isoleucine catabolic process
evidence_type: IDA
original_reference_id: PMID:18996107
qualifier: involved_in
review:
summary: >-
IDA involvement in L-isoleucine catabolism from clinical/biochemical study of
MHBD-deficient patients (deficient MHBD activity, isoleucine-pathway
metabolites). Core biological process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:18996107
supporting_text: >-
2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency
- term:
id: GO:0006550
label: L-isoleucine catabolic process
evidence_type: IDA
original_reference_id: PMID:19706438
qualifier: involved_in
review:
summary: >-
IDA involvement in isoleucine catabolism; the disease mutant fails to
dehydrogenate 2-methyl-3-hydroxybutyryl-CoA. Core biological process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:19706438
supporting_text: >-
HSD10(E249Q) was unable to catalyze the dehydrogenation of
2-methyl-3-hydroxybutyryl-CoA
- term:
id: GO:0044594
label: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA 17-beta-hydroxysteroid dehydrogenase activity from the expanded substrate
screen. Real but weak intrinsic steroid activity; non-core.
action: KEEP_AS_NON_CORE
reason: Weak in-vitro steroid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
3alpha-OH and 17beta-OH activities with sex steroids
- term:
id: GO:0047015
label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:18996107
qualifier: enables
review:
summary: >-
IDA MHBD activity measured in patient fibroblasts. Core physiological catalytic
activity (isoleucine catabolism). Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:18996107
supporting_text: >-
MHBD activity was clearly deficient in males
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA (3S)-3-hydroxyacyl-CoA dehydrogenase activity from the substrate screen.
Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
In addition to the known hydroxyacyl-CoA dehydrogenase
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: involved_in
review:
summary: >-
IDA involvement in fatty acid beta-oxidation (short/medium-chain
3-hydroxyacyl-CoA dehydrogenase step). Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: involved_in
review:
summary: >-
IDA involvement in bile-acid metabolism, from the in-vitro bile-acid
dehydrogenase activities and bile-acid isomerization proposal. Real but in-vitro;
physiological contribution unestablished. Non-core.
action: KEEP_AS_NON_CORE
reason: >-
Based on in-vitro bile-acid activities; physiological role in bile-acid
biosynthesis not established.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
participates in bile acid isomerization
- term:
id: GO:0008207
label: C21-steroid hormone metabolic process
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: involved_in
review:
summary: >-
IDA involvement in C21-steroid (glucocorticoid/gestagen) metabolism, from the
20-beta/21-OH oxidation activities. In-vitro steroid metabolism; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid metabolism, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
oxidize the 20beta-OH and 21-OH groups in C21 steroids
- term:
id: GO:0008209
label: androgen metabolic process
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: involved_in
review:
summary: >-
IDA involvement in androgen metabolism, from testosterone/androstanediol
dehydrogenase activities. In-vitro steroid metabolism; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
3alpha-OH and 17beta-OH activities with sex steroids
- term:
id: GO:0008210
label: estrogen metabolic process
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: involved_in
review:
summary: >-
IDA involvement in estrogen metabolism, from 17-beta-estradiol dehydrogenase
activity. In-vitro steroid metabolism; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
17beta-OH activities with sex steroids
- term:
id: GO:0008709
label: cholate 7-alpha-dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA cholate 7-alpha-dehydrogenase activity from the substrate screen. Real
in-vitro bile-acid activity; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro bile-acid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
(5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
- term:
id: GO:0042645
label: mitochondrial nucleoid
evidence_type: IDA
original_reference_id: PMID:24703694
qualifier: located_in
review:
summary: >-
IDA localization to the mitochondrial nucleoid, where RNase P/ELAC2 initiate
tRNA processing and ribosome assembly. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:24703694
supporting_text: >-
associate with nucleoids to initiate RNA processing and ribosome assembly
- term:
id: GO:0047015
label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:19706438
qualifier: enables
review:
summary: >-
IDA MHBD activity; disease mutant loses dehydrogenation of
2-methyl-3-hydroxybutyryl-CoA. Core physiological catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:19706438
supporting_text: >-
HSD10(E249Q) was unable to catalyze the dehydrogenation of
2-methyl-3-hydroxybutyryl-CoA
- term:
id: GO:0047035
label: testosterone dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:12917011
qualifier: enables
review:
summary: >-
IDA testosterone dehydrogenase activity from the substrate screen. In-vitro
steroid side activity; non-core.
action: KEEP_AS_NON_CORE
reason: In-vitro steroid side activity, not the evolved core function.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
3alpha-OH and 17beta-OH activities with sex steroids
- term:
id: GO:0062173
label: brexanolone metabolic process
evidence_type: IDA
original_reference_id: PMID:19706438
qualifier: involved_in
review:
summary: >-
IDA involvement in brexanolone (allopregnanolone) metabolism: HSD17B10 oxidizes
the 3-alpha-OH of this neurosteroid GABA-A modulator, and disease mutants lose
this activity. A genuine, potentially neurologically relevant side activity;
kept as non-core relative to the isoleucine/tRNA core roles.
action: KEEP_AS_NON_CORE
reason: >-
Real neurosteroid activity of possible pathophysiological relevance, but a side
activity rather than the evolved core function.
supported_by:
- reference_id: PMID:19706438
supporting_text: >-
the oxidation of allopregnanolone, a positive modulator of the
gamma-aminobutyric acid type A receptor
- term:
id: GO:0000049
label: tRNA binding
evidence_type: IDA
original_reference_id: PMID:29040705
qualifier: enables
review:
summary: >-
IDA tRNA binding: the MRPP1/2 (TRMT10C/SDR5C1) complex binds and retains
mitochondrial pre-tRNA throughout maturation. tRNA binding is the
subunit-level molecular activity underlying HSD17B10/MRPP2's structural role in
RNase P/tRNA processing. Accept as a core molecular function.
action: ACCEPT
supported_by:
- reference_id: PMID:29040705
supporting_text: >-
it retains the tRNA product from the 5'-processing step
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:25925575
qualifier: enables
review:
summary: >-
IDA 3-hydroxyacyl-CoA dehydrogenase activity assayed for disease mutants
alongside RNase P/tRNA functions. Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:25925575
supporting_text: >-
pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing
and methylation
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:28888424
qualifier: enables
review:
summary: >-
IDA 3-hydroxyacyl-CoA dehydrogenase activity for the V12L/V176M disease mutants
(reduced dehydrogenase activity). Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:28888424
supporting_text: >-
Both mutant proteins showed significant reduction in the dehydrogenase,
methyltransferase and tRNA processing activities compared to wildtype
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29040705
qualifier: enables
review:
summary: >-
IPI protein-binding to TRMT10C (Q7L0Y3) from the MRPP1/2 tRNA-maturation
platform study. Real and central, but bare "protein binding" is uninformative;
functional meaning captured by the RNase P complex/process annotations.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; TRMT10C interaction captured by
complex/process annotations.
- term:
id: GO:0030678
label: mitochondrial ribonuclease P complex
evidence_type: IDA
original_reference_id: PMID:25925575
qualifier: part_of
review:
summary: >-
IDA part_of the mitochondrial RNase P complex; disease mutations disrupt
complex assembly/interaction with TRMT10C. Core cellular component. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:25925575
supporting_text: >-
moonlighting as a component of human mitochondrial RNase P
- term:
id: GO:0030678
label: mitochondrial ribonuclease P complex
evidence_type: IDA
original_reference_id: PMID:28888424
qualifier: part_of
review:
summary: >-
IDA part_of the mitochondrial RNase P complex (MRPP1/MRPP2/MRPP3). Core
cellular component. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:28888424
supporting_text: >-
in a complex with MRPP1 and MRPP3 (also known as PRORP) proteins for 5'-end
processing of mitochondrial precursor tRNA
- term:
id: GO:0051289
label: protein homotetramerization
evidence_type: IDA
original_reference_id: PMID:25925575
qualifier: involved_in
review:
summary: >-
IDA protein homotetramerization; HSD17B10 functions as a homotetramer and some
disease mutations disrupt tetramerization. A genuine, structurally important
property. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:25925575
supporting_text: >-
Some mutations disrupt the homotetramerization of SDR5C1
- term:
id: GO:0070901
label: mitochondrial tRNA methylation
evidence_type: IDA
original_reference_id: PMID:25925575
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9); disease mutations
impair methylation. Genuine RNase P subcomplex role. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:25925575
supporting_text: >-
pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing
and methylation
- term:
id: GO:0070901
label: mitochondrial tRNA methylation
evidence_type: IDA
original_reference_id: PMID:28888424
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA methylation; V12L/V176M mutants show
reduced methyltransferase activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:28888424
supporting_text: >-
N1-methylation of purines at position 9 of mitochondrial tRNA
- term:
id: GO:0097745
label: mitochondrial tRNA 5'-end processing
evidence_type: IDA
original_reference_id: PMID:24549042
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA 5'-end processing; knock-down / patient
mutation impairs heavy-strand transcript processing. Core biological process.
Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:24549042
supporting_text: >-
evidence of impaired processing of precursor tRNA transcripts of the
mitochondrial heavy strand
- term:
id: GO:0097745
label: mitochondrial tRNA 5'-end processing
evidence_type: IDA
original_reference_id: PMID:25925575
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA 5'-end processing; disease mutations
impair RNase P tRNA processing. Core biological process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:25925575
supporting_text: >-
the enzyme removing 5'-extensions of tRNAs, an early and crucial step in tRNA
maturation
- term:
id: GO:0097745
label: mitochondrial tRNA 5'-end processing
evidence_type: IDA
original_reference_id: PMID:28888424
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA 5'-end processing; disease mutants show
reduced tRNA processing. Core biological process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:28888424
supporting_text: >-
5'-end processing of mitochondrial precursor tRNA
- term:
id: GO:0097745
label: mitochondrial tRNA 5'-end processing
evidence_type: IDA
original_reference_id: PMID:29040705
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA 5'-end processing; MRPP1/2 mediates
RNase P 5'-leader removal. Core biological process. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:29040705
supporting_text: >-
MRPP1/2 is not only responsible for mitochondrial RNase P-based 5'-leader
removal
- term:
id: GO:1990180
label: mitochondrial tRNA 3'-end processing
evidence_type: IDA
original_reference_id: PMID:29040705
qualifier: involved_in
review:
summary: >-
IDA involvement in mitochondrial tRNA 3'-end processing: the MRPP1/2 platform
retains the tRNA after 5'-cleavage and enhances ELAC2-catalyzed 3'-processing.
Real platform-associated role; kept as non-core relative to the 5'-processing
core (HSD17B10 does not itself perform 3'-cleavage).
action: KEEP_AS_NON_CORE
reason: >-
Platform-supported 3'-processing role; ancillary to the core RNase P
5'-processing function.
supported_by:
- reference_id: PMID:29040705
supporting_text: >-
significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17
of the 22 tRNAs
- term:
id: GO:0007005
label: mitochondrion organization
evidence_type: IMP
original_reference_id: PMID:20077426
qualifier: involved_in
review:
summary: >-
IMP involvement in mitochondrion organization: knock-down/knock-out and disease
mutations disrupt mitochondrial structural integrity (cristae) independently of
dehydrogenase activity. This reflects the essential non-enzymatic (RNase
P/tRNA-processing) role. A genuine but downstream/pleiotropic process; kept as
non-core.
action: KEEP_AS_NON_CORE
reason: >-
Genuine IMP phenotype but a downstream consequence of the RNase P/tRNA-processing
role; more specific molecular roles capture the core function.
supported_by:
- reference_id: PMID:20077426
supporting_text: >-
a property of HSD10 independent of its enzymatic activity is essential for
structural and functional integrity of mitochondria
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:23042678
qualifier: enables
review:
summary: >-
IDA 3-hydroxyacyl-CoA dehydrogenase activity (CAFA-assigned) associated with the
methyltransferase-subcomplex study. Core catalytic activity. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:23042678
supporting_text: >-
a fatty and amino acid degradation enzyme in tRNA methylation
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23042678
qualifier: enables
review:
summary: >-
IPI protein-binding to TRMT10C (Q7L0Y3), the methyltransferase partner. Real and
central, but bare "protein binding" is uninformative; captured by the RNase P /
methyltransferase complex annotations.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative generic protein-binding term; TRMT10C interaction captured by
complex annotations.
- term:
id: GO:0030678
label: mitochondrial ribonuclease P complex
evidence_type: TAS
original_reference_id: PMID:23042678
qualifier: part_of
review:
summary: >-
TAS part_of the mitochondrial RNase P complex. Core cellular component,
independently supported by IDA. Accept.
action: ACCEPT
supported_by:
- reference_id: PMID:23042678
supporting_text: >-
a subcomplex of human mitochondrial RNase P
- term:
id: GO:0003723
label: RNA binding
evidence_type: HDA
original_reference_id: PMID:22681889
qualifier: enables
review:
summary: >-
HDA RNA binding from a global mRNA-interactome capture screen. HSD17B10 does
bind tRNA (specifically captured by GO:0000049), but this high-throughput
generic "RNA binding" from a poly(A)-mRNA capture experiment is a non-specific
over-annotation for a protein whose relevant RNA ligand is tRNA.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Non-specific high-throughput RNA-binding capture; the specific and relevant
activity (tRNA binding) is separately and better annotated.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-508369
qualifier: located_in
review:
summary: >-
TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism
reaction. Consistent with the authoritative matrix localization. Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Mitochondrion matrix
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6787591
qualifier: located_in
review:
summary: >-
TAS (Reactome) mitochondrial-matrix localization for the tRNA m1G9 methylation
reaction. Consistent with authoritative matrix localization. Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Mitochondrion matrix
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6787594
qualifier: located_in
review:
summary: >-
TAS (Reactome) mitochondrial-matrix localization for the tRNA m1A9 methylation
reaction. Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Mitochondrion matrix
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70837
qualifier: located_in
review:
summary: >-
TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism
(MHBD) reaction. Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Mitochondrion matrix
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9838081
qualifier: located_in
review:
summary: >-
TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein
degradation context). Localization consistent with authoritative matrix
localization. Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Mitochondrion matrix
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9838093
qualifier: located_in
review:
summary: >-
TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein binding
context). Accept.
action: ACCEPT
supported_by:
- reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
supporting_text: >-
Mitochondrion matrix
- term:
id: GO:0005739
label: mitochondrion
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
ISS mitochondrial localization by orthology to mouse (O08756). Consistent with
all experimental data. Accept.
action: ACCEPT
- term:
id: GO:0005737
label: cytoplasm
evidence_type: TAS
original_reference_id: PMID:9338779
qualifier: located_in
review:
summary: >-
TAS cytoplasm from the 1997 ERAB discovery paper, which reported an
ER/plasma-membrane-associated Aβ-binding protein. This localization is a legacy
mis-assignment superseded by all subsequent work establishing the protein as
mitochondrial (matrix/nucleoid). Over-annotated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Legacy mislocalization from the original ERAB paper; superseded by mitochondrial
matrix/nucleoid localization in all later studies.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human form is localized to mitochondria
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: PMID:9338779
qualifier: located_in
review:
summary: >-
TAS plasma membrane from the 1997 ERAB discovery paper. A legacy
mis-assignment; the protein is a mitochondrial-matrix enzyme with no established
plasma-membrane role. Over-annotated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Legacy mislocalization from the original ERAB paper; superseded by mitochondrial
localization.
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human form is localized to mitochondria
- term:
id: GO:0006629
label: lipid metabolic process
evidence_type: TAS
original_reference_id: PMID:9338779
qualifier: involved_in
review:
summary: >-
TAS broad "lipid metabolic process" from the 1997 ERAB paper. HSD17B10 does have
fatty-acid/cardiolipin/steroid-lipid activities, so a lipid-metabolism parent is
not wrong, but this is a very general term captured better by fatty acid
beta-oxidation. Kept as non-core.
action: KEEP_AS_NON_CORE
reason: Over-general parent; more specific lipid processes are separately annotated.
- term:
id: GO:0008709
label: cholate 7-alpha-dehydrogenase (NAD+) activity
evidence_type: TAS
original_reference_id: PMID:9338779
qualifier: enables
review:
summary: >-
TAS cholate 7-alpha-dehydrogenase activity attributed to the 1997 ERAB paper,
which did NOT establish bile-acid activity (it described an Aβ-binding
dehydrogenase); the bile-acid activity was actually characterized later
(PMID:12917011, separately annotated by IDA). The activity itself is a real but
non-core in-vitro side activity, so this is kept as non-core; note that the 1997
citation is a legacy mis-attribution and the true support is PMID:12917011.
action: KEEP_AS_NON_CORE
reason: >-
Real but non-core in-vitro bile-acid side activity; the cited 1997 paper does not
actually support it (true support is the later IDA, PMID:12917011).
supported_by:
- reference_id: PMID:12917011
supporting_text: >-
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
(5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
core_functions:
- description: >-
NAD+-dependent (S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) acting in
the mitochondrial matrix in L-isoleucine catabolism, oxidizing
(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to 2-methyl-3-oxobutanoyl-CoA; the enzyme
also has broad short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase activity in
fatty acid beta-oxidation. Deficiency of this activity causes the MHBD organic
aciduria.
molecular_function:
id: GO:0047015
label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
directly_involved_in:
- id: GO:0006550
label: L-isoleucine catabolic process
- id: GO:0006635
label: fatty acid beta-oxidation
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:19706438
supporting_text: >-
HSD10(E249Q) was unable to catalyze the dehydrogenation of
2-methyl-3-hydroxybutyryl-CoA
- reference_id: PMID:20077426
supporting_text: >-
the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD)
involved in isoleucine metabolism
- reference_id: PMID:9553139
supporting_text: >-
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
D-isomers.
- description: >-
Broad-substrate NAD+-dependent (S)-3-hydroxyacyl-CoA dehydrogenase catalyzing the
third step of mitochondrial fatty acid beta-oxidation, with NAD+ as the required
cofactor bound in a Rossmann fold. This is the family-defining SDR catalytic
activity underlying the MHBD and other hydroxyacyl-CoA/hydroxysteroid activities.
molecular_function:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:9553139
supporting_text: >-
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
D-isomers.
- reference_id: PMID:12917011
supporting_text: >-
In addition to the known hydroxyacyl-CoA dehydrogenase
- description: >-
Essential non-catalytic (moonlighting) structural subunit MRPP2 of mitochondrial
RNase P. As a homotetramer it binds mitochondrial pre-tRNA and, together with the
methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3, carries out 5'-end
processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex also acts as a
tRNA-maturation platform and enables N1-methylation of purine-9 (m1A9/m1G9). This
role is independent of the enzyme's dehydrogenase activity, and its loss underlies
the severity of HSD10 mitochondrial disease.
molecular_function:
id: GO:0000049
label: tRNA binding
directly_involved_in:
- id: GO:0097745
label: mitochondrial tRNA 5'-end processing
- id: GO:0070901
label: mitochondrial tRNA methylation
in_complex:
id: GO:0030678
label: mitochondrial ribonuclease P complex
supported_by:
- reference_id: PMID:18984158
supporting_text: >-
human mitochondrial RNase P is a protein enzyme that does not require a
trans-acting RNA component for catalysis
- reference_id: PMID:29040705
supporting_text: >-
it retains the tRNA product from the 5'-processing step
- reference_id: PMID:23042678
supporting_text: >-
the human mitochondrial enzyme, moreover, requires a short-chain dehydrogenase
as a partner protein
- reference_id: PMID:20077426
supporting_text: >-
a property of HSD10 independent of its enzymatic activity is essential for
structural and functional integrity of mitochondria
proposed_new_terms: []
suggested_questions:
- question: >-
Which of HSD17B10's catalytic activities (isoleucine-pathway MHBD, general
3-hydroxyacyl-CoA, neurosteroid/allopregnanolone, cardiolipin phospholipase) are
physiologically significant in vivo versus in-vitro artifacts of a broad-specificity
SDR active site?
- question: >-
How does the non-catalytic RNase P/tRNA-processing role mechanistically account for
HSD10 disease severity, and can it be uncoupled therapeutically from the metabolic
(isoleucine) role?
- question: >-
Does the neurosteroid (allopregnanolone/brexanolone) oxidation activity contribute
to the neurological phenotype of HSD10 disease independently of tRNA processing?
suggested_experiments:
- description: >-
Separation-of-function mutants that selectively abolish either dehydrogenase
activity or RNase P/TRMT10C-binding, tested in patient-derived and knockout cells
for mitochondrial tRNA processing, respiratory chain assembly, and viability.
- description: >-
Quantitative in-vivo metabolic flux analysis of isoleucine catabolism and
neurosteroid (allopregnanolone) levels in HSD10-deficient models to define which
metabolic defects contribute to neuropathology.
- description: >-
Structural and biochemical dissection of how the HSD17B10 homotetramer scaffolds
TRMT10C and pre-tRNA across the sequential 5'-processing, methylation, 3'-processing
and CCA-addition steps.
references:
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:9338779
title: An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity
in Alzheimer's disease.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
The original ERAB/Aβ discovery paper. Establishes the Aβ (APP) interaction, but
its cytoplasm/plasma-membrane/ER localization and bile-acid TAS assignments are
legacy mis-assignments superseded by later mitochondrial-matrix work.
- id: PMID:9553139
title: A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an
amyloid beta-peptide-binding protein involved in Alzheimer's disease.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Cloning and biochemical characterization establishing the core NAD+-dependent
(3S)-3-hydroxyacyl-CoA dehydrogenase activity; identical to ERAB.
- id: PMID:10600649
title: Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities
of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Kinetic characterization showing the alcohol/hydroxysteroid activities are orders
of magnitude weaker than the 3-hydroxyacyl-CoA activity, supporting non-core status
of the steroid/ADH side activities.
- id: PMID:12917011
title: 'Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid
dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone
metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Definitive substrate screen and mitochondrial localization; source of most steroid
and bile-acid MF/BP annotations (in-vitro, non-core).
- id: PMID:18984158
title: 'RNase P without RNA: identification and functional reconstitution of the
human mitochondrial tRNA processing enzyme.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Identified HSD17B10/MRPP2 as an essential subunit of the protein-only mitochondrial
RNase P; foundational for the tRNA-processing core function.
- id: PMID:18996107
title: 'Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase
(MHBD) deficiency: difficulties in the diagnosis.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Patient/carrier study of MHBD deficiency supporting the isoleucine-catabolism role.
- id: PMID:19706438
title: Mental retardation linked to mutations in the HSD17B10 gene interfering with
neurosteroid and isoleucine metabolism.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Links disease mutations to loss of both MHBD (isoleucine) and allopregnanolone
(neurosteroid) oxidation; source of the brexanolone metabolic process annotation.
- id: PMID:20077426
title: A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is
required for mitochondrial integrity and cell survival.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Key evidence that disease severity is independent of enzymatic activity and driven
by an essential non-enzymatic mitochondrial-integrity function; also the 1.2 A
crystal structure.
- id: PMID:21593607
title: Involvement of human ELAC2 gene product in 3' end processing of mitochondrial
tRNAs.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
ELAC2 mitochondrial 3'-processing study; source of a NAS mitochondrion
localization for HSD17B10 in the context of the tRNA-processing machinery.
- id: PMID:22681889
title: The mRNA-bound proteome and its global occupancy profile on protein-coding
transcripts.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Global mRNA-interactome capture screen; source of the non-specific HDA "RNA
binding" annotation, marked over-annotated (the relevant ligand is tRNA).
- id: PMID:23042678
title: A subcomplex of human mitochondrial RNase P is a bifunctional methyltransferase--extensive
moonlighting in mitochondrial tRNA biogenesis.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Establishes the MRPP1-MRPP2 subcomplex as the m1A9/m1G9 methyltransferase requiring
HSD17B10 as a non-catalytic partner.
- id: PMID:24549042
title: Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause
loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Shows HSD17B10 maintains MRPP1 levels and that its loss impairs heavy-strand
mitochondrial tRNA processing; disease-relevant.
- id: PMID:24703694
title: Initial steps in RNA processing and ribosome assembly occur at mitochondrial
DNA nucleoids.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Localizes RNase P/ELAC2 to mtDNA nucleoids; supports the mitochondrial-nucleoid
localization annotation.
- id: PMID:25575635
title: Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript
processing.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Supports that HSD10 disease pathology stems from defective mtDNA transcript (tRNA)
processing rather than the metabolic defect. Cited in notes; not an existing GOA
annotation source.
- id: PMID:25925575
title: 'Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the
human mitochondrial RNase P complex.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Shows disease mutations impair dehydrogenation, tRNA processing, methylation,
homotetramerization and TRMT10C interaction; source of several core annotations.
- id: PMID:26338420
title: Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Establishes the cardiolipin phospholipase C-like (cardiolipin dehydrogenase)
activity, inhibited by Aβ; a distinct in-vitro moonlighting activity (non-core).
- id: PMID:26950678
title: A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase
P complex causes X-linked intractable epilepsy and neurodevelopmental regression.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
K212E patient mutation impairing SDR5C1-dependent RNase P activities; source of an
EXP dehydrogenase annotation.
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput interactome study; source of a bare protein-binding (TRMT10C) IPI,
marked over-annotated.
- id: PMID:28888424
title: Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase
and mitochondrial tRNA modification functions of the encoded protein.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
V12L/V176M patient mutations reduce dehydrogenase, methyltransferase and tRNA
processing; clean statement of the dual catalytic/non-catalytic functions.
- id: PMID:29040705
title: The MRPP1/MRPP2 complex is a tRNA-maturation platform in human mitochondria.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Shows MRPP1/2 retains tRNA after 5'-cleavage, enhances ELAC2 3'-processing and
presents tRNA to the CCA-adding enzyme; source of tRNA-binding and processing
annotations.
- id: PMID:29128334
title: A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration
Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Mitochondrial interactome map; source of bare protein-binding IPIs (EEF2, TRAP1)
of unclear functional significance, marked over-annotated.
- id: PMID:29880640
title: Structural insight into the human mitochondrial tRNA purine N1-methyltransferase
and ribonuclease P complexes.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Structural study of the MRPP1/MRPP2 and RNase P complexes; source of RNase P
complex, mitochondrion and 5'-processing annotations.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Neurodegeneration interactome; source of a bare protein-binding (APP/Aβ) IPI,
marked over-annotated.
- id: PMID:32825572
title: 'Study of Biomolecular Interactions of Mitochondrial Proteins Related to
Alzheimer''s Disease: Toward Multi-Interaction Biomolecular Processes.'
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Alzheimer-related mitochondrial interaction study; source of a bare protein-binding
(Aβ peptide) IPI, marked over-annotated.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteome-scale interactome; source of a bare protein-binding (TRMT10C) IPI, marked
over-annotated.
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: High-confidence mitochondrial proteome; supports mitochondrion localization.
- id: PMID:38824131
title: Structural basis for human mitochondrial tRNA maturation.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Cryo-EM of the four mt-tRNA maturation steps; supports the maturation-platform,
CCA-addition and catalytic-complex annotations.
- id: PMID:39516281
title: Structural basis of 3'-tRNA maturation by the human mitochondrial RNase Z
complex.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Cryo-EM of the mitochondrial RNase Z (ELAC2/SDR5C1/TRMT10C) complex; supports the
3'-processing and endoribonuclease-complex annotations.
- id: Reactome:R-HSA-508369
title: alpha-methylacetoacetyl-CoA + NADH + H+ <=> alpha-methyl-beta-hydroxybutyryl-CoA
+ NAD+
findings: []
- id: Reactome:R-HSA-6787591
title: TRMT10C:HSD17B10 (TRMT10C:SDR5C1) of mitochondrial RNase P methylates guanosine-9
in tRNA yielding 1-methylguanosine-9
findings: []
- id: Reactome:R-HSA-6787594
title: TRMT10C:HSD17B10 (TRMT10C:SDR5C1) methylates adenosine-9 in tRNA yielding
1-methyladenosine-9
findings: []
- id: Reactome:R-HSA-70837
title: alpha-methyl-beta-hydroxybutyryl-CoA + NAD+ <=> alpha-methylacetoacetyl-CoA
+ NADH + H+
findings: []
- id: Reactome:R-HSA-9838081
title: LONP1 degrades mitochondrial matrix proteins
findings: []
- id: Reactome:R-HSA-9838093
title: LONP1 binds mitochondrial matrix proteins
findings: []